ONCOLOGIE DR. DUGARDYN J.L.
0463.999.203 · rovalta.com · 28/09/2026
NORMAL SITUATION
ONCOLOGIE DR. DUGARDYN J.L.
Company — Normal situation.
Financial year 2023 · Closed on 30/06/2023
Net result24,8 k €+262,5 %over 1 year
Gross margin14,4 k €+987,8 %over 1 year
Equity1,7 M €+40,4 %over 1 year
Overview
Identity
Source · BCE/KBOONCOLOGIE DR. DUGARDYN J.L. is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0463.999.203
- Legal form
- Private company with limited liability
- Contributed capital
- 18 600,00 €
- Latest accounts
- 30/06/2023
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 25 filingsTrend over 15 financial years
| 2023 | 2022 | 2019 | 2018 | 2017 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 14,4 k € | +988% | 1,3 k € | -99.5% | 283,6 k € | +23.9% | 228,8 k € | +1.7% | 225,1 k € |
| EBITDA | 10,7 k € | +535% | -2,5 k € | -101% | 280 k € | +24.5% | 224,9 k € | +2.0% | 220,5 k € |
| Operating result | 9,6 k € | +156% | -17,2 k € | -106% | 270,5 k € | +25.0% | 216,3 k € | +1.8% | 212,5 k € |
| Net result | 24,8 k € | +263% | -15,3 k € | -109% | 168 k € | +12.2% | 149,7 k € | -13.3% | 172,8 k € |
| Balance sheet | |||||||||
| Equity | 1,7 M € | +40.4% | 1,2 M € | +33.9% | 885,5 k € | -40.3% | 1,5 M € | +11.2% | 1,3 M € |
| Total assets | 1,7 M € | +35.2% | 1,2 M € | +26.2% | 980,6 k € | -38.7% | 1,6 M € | +17.1% | 1,4 M € |
| Cash | 3 k € | -94.5% | 53,6 k € | -75.4% | 218,1 k € | -17.0% | 262,8 k € | -30.6% | 378,6 k € |
| Debts | 5,4 k € | -89.8% | 52,6 k € | -44.8% | 95,2 k € | -18.0% | 116 k € | +259% | 32,3 k € |
Board of directors
Source · NBB, accounts to 30/06/20230 active · 5 ended
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Jean Louis Dugardyn | Director28/12/2018 → 29/12/2028Liquidator28/12/2018 → 30/06/2023Associate18/08/2008 → 18/08/2018 | |
Jean-Louis Dugardyn | Manager18/08/2008 → 18/08/2018 |
Financials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2022 | 01/07/2021 | 01/07/2020 | 01/07/2019 | 01/07/2018 | 01/07/2017 |
| Closing of the financial year | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 | 30/06/2019 | 30/06/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/10/2023 | 20/02/2023 | 27/01/2022 | 01/02/2021 | 15/01/2020 | 15/01/2019 |
| General meeting | 18/09/2023 | 31/12/2022 | 30/12/2021 | 30/12/2020 | 16/12/2019 | 29/12/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 25 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2023 | 18/09/2023 | 03/10/2023 | Dutch | |
| Micro model | 30/06/2022 | 31/12/2022 | 20/02/2023 | Dutch | |
| Micro model | 30/06/2021 | 30/12/2021 | 27/01/2022 | Dutch | |
| Micro model | 30/06/2020 | 30/12/2020 | 01/02/2021 | Dutch | |
| Micro model | 30/06/2019 | 16/12/2019 | 15/01/2020 | Dutch | |
| Micro model | 30/06/2018 | 29/12/2018 | 15/01/2019 | Dutch | |
| Micro model | 30/06/2017 | 29/12/2017 | 11/01/2018 | Dutch | |
| Abridged model | 30/06/2016 | 29/12/2016 | 17/01/2017 | Dutch | |
| Abridged model | 30/06/2015 | 14/12/2015 | 16/12/2015 | Dutch | |
| Abridged model | 30/06/2014 | 27/12/2014 | 29/01/2015 | Dutch | |
| Abridged model | 30/06/2013 | 31/12/2013 | 31/01/2014 | Dutch | |
| Abridged model | 30/06/2012 | 31/12/2012 | 06/02/2013 | Dutch | |
| Abridged model | 30/06/2011 | 31/12/2011 | 13/02/2012 | Dutch | |
| Abridged model | 30/06/2010 | 31/12/2010 | 26/01/2011 | Dutch | |
| Abridged model | 30/06/2009 | 29/12/2009 | 20/01/2010 | Dutch | |
| Abridged model | 30/06/2008 | 08/12/2008 | 14/12/2008 | Dutch | |
| Abridged model | 30/06/2007 | 14/12/2007 | 31/12/2007 | Dutch | |
| Abridged model | 30/06/2006 | 18/12/2006 | 20/12/2006 | Dutch | |
| Abridged model | 30/06/2005 | 13/12/2005 | 20/12/2005 | Dutch | |
| Abridged model | 30/06/2004 | 20/12/2004 | 14/01/2005 | Dutch | |
| Abridged model | 30/06/2003 | 27/12/2003 | 15/01/2004 | Dutch | |
| Abridged model | 30/06/2002 | 12/12/2002 | 23/12/2002 | Dutch | |
| Abridged model | 30/06/2001 | 03/12/2001 | 24/12/2001 | Dutch | |
| Abridged model | 30/06/2000 | 27/11/2000 | 01/12/2000 | Dutch | |
| Abridged model | 30/06/1999 | 30/09/1999 | 15/10/1999 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20230 active · 5 ended
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
Jean Louis Dugardyn | Director28/12/2018 → 29/12/2028Liquidator28/12/2018 → 30/06/2023Associate18/08/2008 → 18/08/2018 | |
Jean-Louis Dugardyn | Manager18/08/2008 → 18/08/2018 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution22/12/2023AFSLUITING VEREFFENING MET VERKRIJGING ONROEREND GOED
- Dissolution20/07/2023RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - ONTSLAGEN - BENOEMINGEN
- Mandates11/02/2019ONTSLAGEN - BENOEMINGEN
- Other13/11/2018STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Capital / shares24/07/2018KAPITAAL - AANDELEN
- Capital / shares01/07/2014KAPITAAL - AANDELEN
- Mandates05/02/2009ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Name
Registered office
Annual accounts
Filings15 filings
Mandates
Jean Louis Dugardyn
Jean-Louis Dugardyn
1998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
ONCOLOGIE DR. DUGARDYN J.L.
Boekweithofstraat 16, 9120 Beveren-Kruibeke-Zwijndrecht
DirectorLiquidatorAssociate
Manager
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Boekweithofstraat 16, 9120 Beveren-Kruibeke-Zwijndrecht | accounts 2022 → 2023 | Accounts 2023 · 2023-00469664 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| ONCOLOGIE DR. DUGARDYN J.L. | accounts 2022 → 2023 | Accounts 2023 · 2023-00469664 |
Events
- 2023Annual accounts 202324,8 k €↑
- 2022Annual accounts 2022-15,3 k €↓
- 2019Annual accounts 2019168 k €↑
- 2018Annual accounts 2018149,7 k €↓
- 2017Annual accounts 2017172,8 k €↓
- 2016Annual accounts 2016214,7 k €↑
- 2015Annual accounts 2015125,8 k €↑
- 2014Annual accounts 201494,6 k €↓
- 2013Annual accounts 2013128,3 k €↑
- 2012Annual accounts 201258,7 k €↓
- 2011Annual accounts 2011153,2 k €↑
- 2010Annual accounts 2010148,1 k €↑
- 2009Annual accounts 2009-19 k €↓
- 2008Annual accounts 200822,6 k €↓
- 2007Annual accounts 2007134 k €